Assessment of Safety and Antihypertensive Efficacy of a Cardioselective Beta-Blocker Nebivolol in Patients with Hypertension and Concomitant Chronic Obstructive Bronchitis

Kardiologiya

Volumn 42, Issue 11, 2002, Pages 36-39

  Yakushin, S S ^a   Okorokov, V G ^a   Liferov, R A ^a   Fomina, V A ^a   Ivanova, G O ^a  

^a NONE

Author keywords

Chronic obstructive bronchitis; Hypertension; Nebivolol; Treatment

Indexed keywords

BENZOPYRAN DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; ETHANOLAMINE DERIVATIVE; NEBIVOLOL;

ADULT; ARTICLE; CHRONIC BRONCHITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; HYPERTENSION; MALE; MIDDLE AGED;

ADRENERGIC BETA-ANTAGONISTS; ADULT; BENZOPYRANS; BRONCHITIS, CHRONIC; ETHANOLAMINES; HUMANS; HYPERTENSION; MALE; MIDDLE AGED;

EID: 0346673817     PISSN: 00229040     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Cockroft J.R., Chowienczyk P.J., Brett S.E. et al. Nebivololvasodilates human forearm vasculature: Evidence for an L-arginine (NO-dependent mechanism. J Pharmacol Exp Ther 1995;274:1067-1071.
2. Fitzgerald J.D. (Ed). First International Nebivolol Investigators Meetings. Drug Invest 1991;3:Suppl I:I-203.
3. Gao Y., Nagao T., Bond R.A. et al. Nebivolol induces endothelium - dependent relaxdion of canine coronary arteries. J Cardiovasc Pharmacol 1991;7:964-969.
4. Himmelmann A., Hender T., Snoeck E. et al. Haemodynamic effects and pharmacokinetics of oral D- and L-nebivolol in hypertensive patients. Eur J Clin Pharmacol 1996;51:259-264.
5. Stoleru L., Wijns W., van Eyll C. et al. Effects of D-nebivolol and L-nebivolol on left ventricular systolic and diastolic function: comparison with D-L-nebivolol and atenolol. J Cardiovasc Pharmacol 1993;22:183-190.
6. Van Peer A., Snoeck E., Woestenborghs R. et al. Clinical pharmacokinetic of nebivolol: a review. Drug Invest 1991;3:Suppl 1:25-30.
7. Gould S.E. et al. Effect of Nebivolol on lund function in normal subjects: a comparison with atenolol and propranolol. JRF Clin Res Rep 1989;67-555.
8. Naranjo C.A., Busto U., Sellers E.M. et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-245.